主要文件

查看所有文档

SML2142

Silodosin

Name: Silodosin
Brand: SIGMA

≥98% (HPLC), alpha 1-adrenoceptor antagonist, powder

别名:

1-(3-Hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide, Rapaflo, Rapallo, Silodyx, Urief

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₂₅H₃₂F₃N₃O₄

化学文摘社编号:

160970-54-7

分子量:

495.53

NACRES:

NA.77

UNSPSC Code:

12352200

MDL number:

MFCD00930170

Assay:

≥98% (HPLC)

Form:

powder

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

产品名称

Silodosin, ≥98% (HPLC)

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

NC(C1=CC(C[C@@H](C)NCCOC2=C(OCC(F)(F)F)C=CC=C2)=CC3=C1N(CCCO)CC3)=O

InChI

1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1

InChI key

PNCPYILNMDWPEY-QGZVFWFLSA-N

正在寻找类似产品? 访问产品对比指南

Biochem/physiol Actions

Selective alpha 1-adrenoceptor antagonist

Silodosin is a selective alpha 1-adrenoceptor antagonist with high affinity for the ?1A adrenergic receptor, used clinically for the treatment of benign prostatic hyperplasia (BPH).

pictograms

GHS08,GHS07

signalword

Warning

hcodes

H302,H373

pcodes

P301 + P312 + P330 - P314

Hazard Classifications

Acute Tox. 4 Oral - STOT RE 2

target_organs

Liver

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

The role of Silodosin as a new medical expulsive therapy for ureteral stones: a meta-analysis.

Hui Ding et al.

Renal failure, 38(9), 1311-1319 (2016-11-04)

To evaluate the efficacy of Silodosin as a medical expulsive therapy of ureteral stones, we searched PubMed, EMBASE, the Cochrane Library, and CBM up to June 2015. All randomized controlled trials (RCTs) were identified in which patients were randomized to

α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?

Claus G Roehrborn et al.

Advances in therapy, 33(12), 2110-2121 (2016-11-05)

Available α1-blockers (ABs) have different profiles of receptor selectivity. Silodosin exhibits the highest selectivity for the α

Comparison of Silodosin Monotherapy vs Silodosin With Tadalafil Add-on Therapy in Patients With Benign Prostatic Hyperplasia.

Takashi Yoshida et al.

Urology, 106, 153-159 (2017-04-23)

To evaluate the efficacy and safety of add-on therapy with the phosphodiesterase type 5 inhibitor tadalafil for patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH) treated with the α We analyzed 103 patients with LUTS/BPH with

全球贸易项目编号

货号	GTIN
SML2142-10MG	04061835253548
SML2142-50MG	04061835253555

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持